Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical AG : CompuGroup Medical strengthens its market position in the Netherlands

01/12/2012 | 01:32pm EDT

Koblenz, January 12, 2012: CompuGroup Medical today concluded an agreement to acquire 100% of the shares in Microbais Werkmaatschappij B.V.. Microbais is one of the market leaders in ambulatory and pharmacy information systems in the Netherlands. The 2011 turnover is expected to amount to 11.2 million Euro with about 70% recurring revenue and EBITDA is expected to be 2.5 million Euro.

Microbais employs around 90 employees and is headquartered in Amsterdam. Around 475 pharmacies as well as 150 doctors' practices count among the company's customers. This is equivalent to a market share of about 25% within pharmacies and 4% within office-based physicians.

With this acquisition CompuGroup Medical increases its market shares in the Dutch pharmacy and doctor software markets to around 45% and 15% respectively. Customers will be provided with access to the international product platform of CompuGroup Medical and benefit from SAM solutions (intelligent software assisted medicine) that are worldwide leading in terms of innovation and security.

In this transaction CompuGroup Medical also acquires a 51% majority holding in MediPharma Online, a start-up enterprise in the field of networking between patients and pharmacies.

Frank Gotthardt, CEO of CompuGroup Medical AG, underlined the relevance of this acquisition: "After the successful acquisition of Ascon Euroned, today CGM Netherlands, the purchase of Microbais is a crucial step towards extending the market position in the Dutch pharmacy software sector. At the same time we strengthen our coverage in the field of ambulatory information systems. The highly positive feedback from shareholders and employees of Microbais regarding this transaction encourages us in using this excellent start into the year 2012 with full power in the best interest of our customers."

The purchase price amounts to approximately 15,0 million Euro and will be financed from existing cash and credit facilities.

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 385,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 33 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 3,600 highly qualified employees support customers with innovative solutions for
the steadily growing demands of the healthcare system.

Contact for media representatives:
CompuGroup Medical AG
Barbara Müller
Consultant Press & Media
P 49 (0) 261 8000-6100
F 49 (0) 261 8000-3100


© Publicnow 2012
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
07:57aCOMPUGROUP MEDICAL : Deutsche Bank remains its Buy rating
MD
09/16COMPUGROUP MEDICAL : Warburg Research revises his opinion and turns to Neutral
MD
09/15COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
MD
09/15COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
09/15COMPUGROUP MEDICAL : Gets a Sell rating from Baader Bank
MD
09/14COMPUGROUP MEDICAL : Receives a Buy rating from Jefferies
MD
09/14COMPUGROUP MEDICAL :  Medical announces medium-term targets for EBITDA-margin fo..
PU
09/14COMPUGROUP MEDICAL : announces medium-term targets for EBITDA-margin for the fir..
EQ
09/14PRESS RELEASE : CompuGroup Medical announces medium-term targets for EBITDA-marg..
DJ
09/14CompuGroup Medical SE & Co. KGaA Confirms Earnings Guidance for the Year 2021
CI
More news
Analyst Recommendations on COMPUGROUP MEDICAL SOCIETAS EUROPAEA
More recommendations
Financials
Sales 2021 1 022 M 1 198 M 1 198 M
Net income 2021 81,8 M 95,9 M 95,9 M
Net Debt 2021 504 M 590 M 590 M
P/E ratio 2021 50,2x
Yield 2021 0,74%
Capitalization 4 032 M 4 731 M 4 727 M
EV / Sales 2021 4,44x
EV / Sales 2022 4,12x
Nbr of Employees 8 030
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 76,45 €
Average target price 84,30 €
Spread / Average Target 10,3%
EPS Revisions
Managers and Directors
Dirk Wössner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas Müller Vice Chairman & Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA-2.99%4 720
ORACLE CORPORATION33.54%236 551
SAP SE13.86%169 037
INTUIT INC.47.91%153 437
SERVICENOW, INC.18.28%128 992
DOCUSIGN, INC.24.94%54 637